Malignant pleural mesothelioma: Staging systems

Lung Cancer

Volumn 49, Issue SUPPL. 1, 2005, Pages

  Van Schil, P ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Induction therapy; Mesothelioma; PET scan; Pleura; Restaging; Staging; TNM classification

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; DIAGNOSTIC ACCURACY; DRUG RESPONSE; HUMAN; MEASUREMENT; MULTIMODALITY CANCER THERAPY; PATIENT MONITORING; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SOLID TUMOR; TUMOR VOLUME;

HUMANS; MESOTHELIOMA; NEOPLASM STAGING; PLEURAL NEOPLASMS; SEVERITY OF ILLNESS INDEX;

EID: 20444404237     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.03.008     Document Type: Article

References (9)

1. E.G. Butchart, T. Ashcroft, W.C. Barnsley, and M.P. Holden Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients Thorax 31 1976 15 24
2. D.J. Sugarbaker, G.M. Strauss, T.J. Lynch, W. Richards, S.J. Mentzer, and T.H. Lee Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma J Clin Oncol 11 1993 1172 1178
3. International Mesothelioma Interest Group. A proposed new international TNM-staging system for malignant pleural mesothelioma. Chest 1995;108:1122-1128.
4. American Joint Committee on Cancer. Pleural mesothelioma. AJCC Cancer Staging Handbook. Springer-Verlag, New York, 2002:205-209 (Chapter 20).
5. M. Flores, T. Akhurst, M. Gonen, S.M. Larson, and V.W. Rusch Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma J Thorac Cardiovasc Surg 126 2003 11 16
6. J.H. Schouwink, L.S. Kool, E.J. Rutgers, F.A. Zoetmulder, N. van Zandwijk, and M.J. v d Vijver The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma Ann Thorac Surg 75 2003 1715 1718
7. R.J. Van Klaveren, J.G. Aerts, H. de Bruin, G. Giaccone, C. Manegold, and J.P. Van Meerbeeck Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma Lung Cancer 43 2004 63 69
8. F. Monetti, S. Casanova, A. Grasso, M.A. Cafferata, A. Ardizzoni, and C.E. Neumaier Inadequacy of the new response evaluation criteria in solid tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases Lung Cancer 43 2004 71 74
9. M.J. Byrne, and A.K. Nowak Modified RECIST criteria for assessment of response in malignant pleural mesothelioma Ann Oncol 15 2004 257 260